JPMorgan upgrades Bumrungrad Hospital stock rating to Overweight on growth outlook

Published 05/08/2025, 08:50
JPMorgan upgrades Bumrungrad Hospital stock rating to Overweight on growth outlook

Investing.com - JPMorgan has upgraded Bumrungrad Hospital PCL (BH:TB) from Neutral to Overweight and raised its price target to THB220.00 from THB190.00.

The upgrade follows Bumrungrad Hospital’s outperformance against the market by 20% over the past month, driven by broader Thai market optimism and the company’s strong second-quarter earnings results.

JPMorgan cited improved revenue guidance and robust 2Q25 performance as factors likely to drive positive earnings per share revisions and lead to a valuation re-rating for the hospital operator.

The investment bank expressed growing optimism about patient revenue momentum in the Middle East, noting a narrative shift from "not yet at the bottom" to "more markets could be going right than wrong."

Based on these positive developments, JPMorgan has increased its EPS estimates for Bumrungrad Hospital by 2-4% and views the company as a "best-in-class hospital operator" worthy of investment.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.